Found 20 matching trials
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation
PHASE2The availability of antiretroviral therapy (cART) for HIV-1 infection has l...
Location
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV
PHASE2This study is designed to evaluate the safety and efficacy of lefitolimod a...
Location
Dept. of Internal Medicine, University of Utah
First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS
PHASE1This first clinical study of 10-1074-LS will evaluate its safety, tolerabil...
Location
The Rockefeller University
A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection
PHASE2The goal of this study is to test the effectiveness, safety, and tolerabili...
Status
Active Not Recruiting
Location
Ruane Clinical Research Group, Inc.
3BNC117 and 10-1074 in HIV-infected Individuals
PHASE1This is a phase 1b clinical trial to evaluate the safety, pharmacokinetics ...
Location
The Rockefeller University
3BNC117 and 10-1074 in HIV Uninfected Adults
PHASE1This is a phase 1 clinical trial to evaluate the safety and pharmacokinetic...
Location
The Rockefeller University
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
PHASE2RIO is a placebo-controlled double-blinded two arm prospective phase II ran...
Location
Aarhus University Hospital
Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals
PHASE1Background:
Human immunodeficiency virus (HIV) affects the immune system. ...
Location
National Institutes of Health Clinical Center
Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI
PHASE1Participants will receive an infusion of both study drugs (3BNC117-LS and 1...
3BNC117 and 10-1074 in ART-treated Individuals
PHASE1The proposed study is a phase 1, open label, randomized study to evaluate t...
Location
Ragon Institute of MGH, MIT, and Harvard